Elevra Lithium signs 7-year spodumene supply deal with Mangrove Lithium for up to 144,000 dmt a year

• Elevra signed a binding seven-year spodumene concentrate supply deal with Mangrove for output from its Québec NAL mine.
• Contracted volumes set at 122,000 dmt in Year 1, rising to 144,000 dmt from Year 2 on a take-or-pay basis.
• Mangrove can lift annual volumes by up to 20%, subject to NAL capacity; pre-start purchases of up to 72,000 dmt allowed.
• Pricing is market-linked with a floor price above expected production costs; no price ceiling.
• Deal conditions include Mangrove FID by Dec. 31, 2028; commercial operations within three years at at least 50% capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevra Lithium Limited published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608210900PRIMZONEFULLFEED9814128) on August 21, 2026, and is solely responsible for the information contained therein.